Bausch Health Cos Inc. (BHC)

Last Closing Price: 8.47 (2026-11-17)

Company Description

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $10.27B
Net Income (Most Recent Fiscal Year) $157.00M
PE Ratio (Current Year Earnings Estimate) 1.87
PE Ratio (Trailing 12 Months) 1.73
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 0.29
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 1.16
Pre-Tax Margin (Trailing 12 Months) -3.18%
Net Margin (Trailing 12 Months) -7.57%
Return on Equity (Trailing 12 Months) -401.73%
Return on Assets (Trailing 12 Months) 7.34%
Current Ratio (Most Recent Fiscal Quarter) 1.56
Quick Ratio (Most Recent Fiscal Quarter) 1.22
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) 1.90
Book Value per Share (Most Recent Fiscal Quarter) $-0.91
Earnings per Share (Most Recent Fiscal Quarter) $1.77
Earnings per Share (Most Recent Fiscal Year) $3.73
Diluted Earnings per Share (Trailing 12 Months) $-2.29
Stock
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Common Shares Outstanding 374.40M
Free Float 297.01M
Market Capitalization $3.17B
Average Volume (Last 20 Days) 4.93M
Beta (Past 60 Months) 0.30
Percentage Held By Insiders (Latest Annual Proxy Report) 20.67%
Percentage Held By Institutions (Latest 13F Reports) 78.65%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%